The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases

被引:51
作者
Al-Khunaizi, M
Luke, CJ
Askew, YS
Pak, SC
Askew, DJ
Cataltepe, S
Miller, D
Mills, DR
Tsu, C
Brömme, D
Irving, JA
Whisstock, JC
Silverman, GA
机构
[1] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp, Boston, MA 02115 USA
[2] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[3] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
关键词
D O I
10.1021/bi015999x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SQN-5 is a mouse serpin that is highly similar to the human serpins SCCA1 (SERPINB3) and SCCA2 (SERPINB4). Previous studies characterizing the biochemical activity of SQN-5 showed that this serpin, like SCCA2, inhibited the chymotrypsin-like enzymes mast cell chymase and cathepsin G. Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H. These interactions were characterized by stoichiometries of inhibition that were nearly 1:1 and second-order rate constants of > 10(4) M-(1) s(-1). Reactive site loop (RSL) cleavage analysis showed that SQN-5 employed different reactive centers to neutralize the serine and cysteine proteinases. To our knowledge, this is the first serpin that serves as a dual inhibitor of both chymotrypsin-like serine and the papain-like cysteine proteinases by employing an RSL-dependent inhibitory mechanism. The ability of serpins to inhibit both serine and/or papain-like cysteine proteinases may not be a recent event in mammalian evolution. Phylogenetic studies suggested that the SCCA and SQN genes evolved from a common ancestor approximately 250-280 million years ago. When the fact that mammals and birds diverged approximately 3 10 million years ago is considered, an ancestral SCCA/ SQN-like serpin with dual inhibitory activity may be present in many mammalian genomes.
引用
收藏
页码:3189 / 3199
页数:11
相关论文
共 47 条
[1]   Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9 [J].
Annand, RR ;
Dahlen, JR ;
Sprecher, CA ;
de Dreu, P ;
Foster, DC ;
Mankovich, JA ;
Talanian, RV ;
Kisiel, W ;
Giegel, DA .
BIOCHEMICAL JOURNAL, 1999, 342 :655-665
[2]  
AULAK KS, 1993, J BIOL CHEM, V268, P18088
[3]   CHYMOTRYPSIN INHIBITORY ACTIVITY OF NORMAL C1-INHIBITOR AND A P1 ARG TO HIS MUTANT - EVIDENCE FOR THE PRESENCE OF OVERLAPPING REACTIVE CENTERS [J].
AULAK, KS ;
DAVIS, AE ;
DONALDSON, VH ;
HARRISON, RA .
PROTEIN SCIENCE, 1993, 2 (05) :727-732
[4]   A murine ortholog of the human serpin SCCA2 maps to chromosome 1 and inhibits chymotrypsin-like serine proteinases [J].
Bartuski, AJ ;
Kamachi, Y ;
Schick, C ;
Massa, H ;
Trask, BJ ;
Silverman, GA .
GENOMICS, 1998, 54 (02) :297-306
[5]  
BEATTY K, 1980, J BIOL CHEM, V255, P3931
[6]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[7]   MULTIPLE MURINE ALPHA-1-PROTEASE INHIBITOR GENES SHOW UNUSUAL EVOLUTIONARY DIVERGENCE [J].
BORRIELLO, F ;
KRAUTER, KS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9417-9421
[8]  
BROMME D, 1993, J BIOL CHEM, V268, P4832
[9]  
BROMME D, 1994, J BIOL CHEM, V269, P30238
[10]   Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization [J].
Brömme, D ;
Li, ZQ ;
Barnes, M ;
Mehler, E .
BIOCHEMISTRY, 1999, 38 (08) :2377-2385